Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

BACKGROUND: Cancer patients often develop the potentially debilitating condition of anaemia. Numerous controlled studies indicate that erythropoiesis-stimulating agents (ESAs) can raise haemoglobin levels and reduce transfusion requirements in anaemic cancer patients receiving chemotherapy. To evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaspy, J, Crawford, J, Vansteenkiste, J, Henry, D, Rao, S, Bowers, P, Berlin, J A, Tomita, D, Bridges, K, Ludwig, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816662/
https://www.ncbi.nlm.nih.gov/pubmed/20051958
http://dx.doi.org/10.1038/sj.bjc.6605498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816662/
https://www.ncbi.nlm.nih.gov/pubmed/20051958
http://dx.doi.org/10.1038/sj.bjc.6605498

Ejemplares similares